2022 PERT Consortium Annual Meeting Agenda

Wednesday, September 28 Thursday, September 29 Friday, September 30 Saturday, October 1

⇒Return to Main Symposium Page

All sessions EASTERN TIME


Pre-Symposium Activities
Wednesday, September 28

12:30PM – 3:00PM
Annual Business Meeting (non-industry participants only)

3:30PM – 5:30PM
Annual Industry Meeting


Scientific Symposium
Thursday, September 29

7:00AM – 8:00AM: Women in PE Networking Event

8:00AM – 8:40AM: Welcome and Keynote
Welcome
Brent Keeling, MD, Emory University
Keynote: State of PERT in Europe
Stavros Konstantinides, MD, University Medical Center of Mainz

8:45AM – 9:45AM: Risk Stratification and Diagnosis
Moderators: Rachel Rosovsky, MD, Massachusetts General Hospital; Phil Wells, MD, The Ottawa Hospital; Mae West, MD, Jefferson University Hospitals
What’s New In Risk Stratification, Biomarkers And Risk Scores?
Jeff Kline, MD, Wayne State University
CT: Current and Future Directions
Tim Morris, MD, University of California San Diego
ECHO and POCUS
Oren Friedman, MD, Penn Medicine
AI in PE & PERT Activation
Hamid Mojibian, MD, Yale School of Medicine
Q&A

9:45AM – 10:15AM: Break

10:15AM – 11:45AM: Massive PE
Michael McDaniel, MD, Emory University; Mitch Silver, MD, Ohio Health
What would you do? PERT Case Example: Massive PE
Hillary Johnston-Cox, MD, PhD, University of Pennsylvania
Systemic Lysis is the Treatment of Choice
Menno Huisman, MD, Leiden University Medical Center
Catheter Directed Therapy is the New Standard
Drew Klein, MD, Piedmont Healthcare
Early Hemodynamic Support Gives You All Options
Emily Gundert, MD, UT Southwestern
Don’t Forget about Surgery
Joshua Goldberg, MD, Westchester Medical Center
Intubation and Inotropes in Massive PE
Mae West, MD, Jefferson University Hospitals
Transfer of Higher Risk Patients
Parth Rali, MD, Temple University
Q&A and Panel Debate

11:45AM – 1:15PM: Satellite Sessions

1:15PM – 2:45PM: Intermediate High Risk
Moderators: Carin Gonsalves, MD, Jefferson University Hospitals; Jun Li, MD, University Hospitals; Keith Sterling, MD, Inova Health

What would you do? PERT Case Example: Intermediate-High Risk PE with Proximal Acute DVT
Anticoagulation with Rescue Thrombolysis is the Standard of Care
Geno Merli, MD, Jefferson University Hospitals
Catheter Directed Lysis is the Preferred Approach
Peter Monteleone, MD, Ascension Seton Medical Center
Catheter Embolectomy: Why waste time with anything else?
Wisam Jaber, MD, Emory University

IVC Filters
IVC Filters Save Lives
John Moriarty, MD, University of California Los Angeles
IVC Filters Should be Avoided
Mona Ranade, MD, University of California Los Angeles
Don’t Forget About the DVT: Current Management
Suresh Vedantham, MD, Washington University

Debate – Clot in Transit
Catheter Directed Therapy
Carin Gonsalves, MD, Jefferson University Hospitals
Surgery
Brent Keeling, MD, Emory University
Q&A and Panel Debate

2:45PM – 3:15PM: Break

3:15PM – 4:15PM: Workshops

Workshop A: Pulmonary Embolism Response Teams
Moderators: George Davis, PharmD, University of Kentucky;
Charles Grodzin, MD, Emory University
How to Set Up a Team & PERT Partners
Rachel Rosovsky, MD, Massachusetts General Hospital
Building a PERT Ecosystem Across a Large Academic Medical System
Bushra Mina, MD, Northwell Health
Centers of Excellence and The PERT Consortium
Mahir Elder, MD, Heart and Vascular Institute
Steven Pugliese, MD, University of Pennsylvania Health Systems

Q&A

Workshop B: Endovascular PE Intervention
Moderators: Jun Li, MD, University Hospitals; Sanjum Sethi, MD, Columbia University Medical Center
How to Perform Catheter Directed Thrombolysis
Assaf Graif, MD, Christiana Care Health System
How to Perform Mechanical Thrombectomy
Catalin Toma, MD, University of Pittsburgh Medical Center
Managing Interventional PE Complications
Eric Secemsky, MD, Beth Israel Deaconess Medical Center
Hemodynamic Support ABC’s
Sasanka Jayasuriya, MD, Ascension WI
Q&A

Workshop C: Next Generation Imaging for PE
Moderators: Sonia Jasuja, MD, UCLA; Joan Lacomis, MD, University of Pittsburgh
ECHO Views and Anatomy
Andrew Sharp, MD, University Hospital of Wales
Assessing Risk & Hand-Held Options
Chris Barnett, MD, University of California San Francisco
AI Imaging and Workflow
Tom Todoran, MD, Medical University of South Carolina
Update on CTA
Q&A

4:20PM – 4:50PM: Abstract Presentations


Friday, September 30

8:00AM – 8:25AM: Welcome and Keynote
State of the PERT
Brent Keeling, MD, Emory University

8:30AM – 9:30AM: Post-PE Follow-up And Transitions Of Care
Moderators: Tania Ahuja, PharmD, NYU Langone; Geoff Barnes, MD, University of Michigan Health System
Early Discharge from the ED: HOT-PE Trial
Mark Courtney, MD, UT Southwestern
Thrombophilia Testing in PE
Beverley Hunt, MD, OBE, Guys’ and St. Thomas’
Duration of Anticoagulation – Provoked vs Unprovoked VTE?
Geoff Barnes, MD, University of Michigan Health System
Top 10 Questions for the Hematologist
Rachel Rosovsky, MD, Massachusetts General Hospital
Q&A

9:30AM – 10:00AM: Break

10:00AM – 11:00AM: Great Debates In CTEPH And CTED
Moderators: Tim Morris, MD, University of California San Diego; Steven Pugliese, MD, University of Pennsylvania Health Systems
Allison Witkin, MD, Massachusetts General Hospital
Diagnosis of CTEPH and CTED
Richard Channick, MD, University of California Los Angeles
The Impact of Peripheral Venous Disease In CTEPH
Vladimir Lakhter, DO, Temple University School of Medicine
Debate: Will BPA Ever Achieve Equipoise With Endarterectomy Surgery
William Auger, MD, University of California, San Diego
Kenneth Rosenfield, MD, Massachusetts General Hospital
Q&A

11:05AM – 11:40AM: Bleeding And Reversal
Moderators: Scott Cameron, MD, Cleveland Clinic; Beverley Hunt, MD, OBE, Guys’ and St. Thomas’
DOAC Reversal
Tania Ahuja, PharmD, NYU Langone
Anticoagulation and Thrombolysis Reversal
Allison Burnett, PharmD, University of New Mexico
Thrombus Biological Activity and Future Directions
Scott Cameron, MD, Cleveland Clinic
Q&A

11:35AM – 1:05PM: Satellite Sessions

1:05PM – 2:05PM: PERTinent Updates – Best Papers Of The Year
Moderators: Stavros Konstantinides, MD, University Medical Center of Mainz; David Jimenez, MD, University of Alcalá de Henares, Seth Sokol, MD, Jacobai Medical Center
Thromboprophylaxis in Patients with COVID-19. A Brief Update to the CHEST Guideline and Expert Panel Report.
David Jimenez, MD, University of Alcalá de Henares
Impact Of Pulmonary Embolism Response Teams on Acute Pulmonary Embolism: A Systematic Review and Meta-Analysis
Derlis Fleitas Sosa, MD, Temple University

2:10PM – 3:10PM: Pulmonary Embolism Research Collaborative (PERC)
Moderators: Sara Royce, FDA Center for Devices and Radiological Health; Eleni Whatley, PhD, FDA Center for Devices and Radiological Health
PERC – Justification and Goals
Terry Bowers, MD, Beaumont Health
PERC Outcome…Standardized Data Elements
Robert Lookstein, MD, Mount Sinai Hospital
FDA Perspectives – Weaving PERC and Real World Evidence into the Regulatory Process
Eleni Whatley, PhD, FDA Center for Devices and Radiological Health
The Future – PERC II and Unanswered Questions
Kenneth Rosenfield, MD, Massachusetts General Hospital
Q&A

3:10PM – 3:25PM: Break

3:25PM – 4:25PM: Workshops

Workshop D: DVT Intervention
Moderators: Mona Ranade, MD, David Geffen School of Medicine at UCLA; Keith Sterling, MD, Inova
Devices for acute DVT intervention
Yulanka Castro, MD, University Hospitals
Chronic DVT Intervention
Erin Murphy, MD, FACS, Sanger Heart and Vascular
Device Evolution: Stents and Clot Extraction
Akhilesh Sista, MD, Cornell
Q&A

Workshop E: BPA-CTEPH Alliance
Moderators: John Moriarty, MD, University of California Los Angeles
The Challenges of Patient Selection for BPA
Alison Witkin, MD, Massachusetts General Hospital
The Art of Pulmonary Angiography
Vikas Aggarwal, MBBS, University of Michigan Health System
The Tips and Tricks for Performing BPA
Mitul Patel, MD, University of California, San Diego
BPA Outcomes…Is it Only About Pulmonary Hemodynamics?
Rich Krasuski, MD, Duke Department of Medicine
Q&A

Workshop F: Outpatient PERT
Moderators: Nancy Amoroso, MD, NYU Langone; Rachel Rosovsky, MD, Massachusetts General Hospital
How to set up a PE Clinic: Marketing, Cost-Effectiveness, and Getting Administrative Buy-In
Brandon Hooks, DO, Ascension Borgess
Transitions of Care
Vicki McNally, NP, Beaumont Health
Optimal Follow Up for Patients with Acute PE
Geno Merli, MD, Jefferson University Hospitals
Q&A

4:30PM – 5:30PM: Late Breaking Clinical Trials
Moderators: Jay Giri, MD, MPH, Penn Medicine; Jim Horowitz, MD, NYU Langone; ; John Moriarty, University of California Los Angeles; Kenneth Rosenfield, MD, Massachusetts General Hospital; Mona Ranade, University of California Los Angeles; Akhilesh Sista, MD, Cornell; Catalin Toma, University of Pittsburgh Medical Center


Saturday, October 1

7:00AM – 8:00AM: BPA-CTEPH Alliance Session

8:00AM – 8:05AM: Welcome

8:05AM – 9:05AM: Next Frontier in PE Management: Mental Health
Moderators: Leslie Lake, National Blood Clot Alliance; Rachel Rosovsky, MD, Massachusetts General Hospital

Mental Health – The Last Frontier and the Multi Disciplinary Approach to Treating the VTE Patient
Leslie Lake, National Blood Clot Alliance
Jim Horowitz, MD, NYU Langone
Kenneth Rosenfield, MD, Massachusetts General Hospital
Jennifer Brandstetter, MD, University Hospitals

9:10AM – 10:10AM: Prevention
Moderators: Manila Gaddh, MD, Emory University School of Medicine; Alex Spyropoulos, MD, Northwell Health
Post Surgery
Scott Kaatz, DO, Henry Ford Health System
Medical Patients
Karlyn Martin, MD, Northwestern
Cancer Patients
Roy Smith, MD, University of Pittsburgh Medical Center
COVID, Inpatient and Discharge Anticoagulation
Allison Burnett, PharmD, University of New Mexico
Q&A

10:10AM – 10:40AM: Break

10:40AM – 11:40AM: Best Saves and Worst Complications 
Moderators: Suhail Dohad, MD Cedars-Sinai Medical Center; Charles Grodzin, MD, Emory University

11:40AM – 12:40PM: Closing and Adjourn

⇒Return to Top


Behind the Scenes
PERT Conference
September 29 – October 1, 2022
Live Virtual

Jointly Accredited Provider

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Behind the Scenes. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 16.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 16.25 ANCC contact hours.

Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 16.25 knowledge-based CPE contact hours.

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.